Axon Enterprise Inc <AXON.O>: Morgan Stanley Raises Target Price to $640.00 From $600.00
AXON•Related News
Prime Medicine Q2 FY26 net loss narrows to $42.1 million
PRME•
Shift4 slides after cutting annual revenue forecast
FOUR•
Vivani Medical completes dosing in SLIM-1 Phase 1 trial of NPM-139 semaglutide implant for weight management
VANI•
Pacira publishes positive two-year Phase 1 data for PCRX-201 gene therapy in knee osteoarthritis
PCRX•
Hertz Q2 FY26 swings to GAAP profit of $64 million; revenue rises 10% to $2.4 billion
HTZ•